Investor profile
M Ventures has backed 28 European tech companies across 32 funding rounds between 2018 and 2026, joining rounds totalling €1.1B. Most active in Healthtech and Cleantech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| DNA Script | France | 1 | €142M |
| Artios | UK | 1 | €99M |
| iOnctura | Switzerland | 1 | €80M |
| Galecto Biotech | Denmark | 1 | €79M |
| Storm Therapeutics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| DNA Script | Series C | €142M | 2021-10 |
| Artios | Series D+ | €99M | 2025-11 |
| iOnctura | Series B | €80M | 2024-06 |
| Galecto Biotech |
| 2 |
| €76M |
| Lightcast Discovery | UK | 2 | €68M |
| IOmx Therapeutics | Germany | 1 | €65M |
| NRG Therapeutics | UK | 1 | €58M |
| ReproNovo | Switzerland | 1 | €57M |
| FoRx Therapeutics | Switzerland | 2 | €53M |
| Formo | Germany | 1 | €42M |
| LabGenius | UK | 1 | €41M |
| Mosa Meat | Netherlands | 1 | €40M |
| Nucleome Therapeutics | UK | 1 | €38M |
| Enara Bio | UK | 1 | €29M |
| Trimtech Therapeutics | UK | 1 | €29M |
| Micropsi | Germany | 1 | €26M |
| Wiliot | Israel | 1 | €26M |
| NanoSyrinx | UK | 2 | €19M |
| Astraveus | France | 1 | €17M |
| Iktos | France | 1 | €16M |
| beeOLED | Germany | 1 | €13M |
| Anavo Therapeutics | Netherlands | 1 | €8.5M |
| Abselion | UK | 1 | €8.0M |
| Scipio Bioscience | France | 1 | €6.0M |
| IonKraft | Germany | 1 | €3.5M |
| aveni | France | 1 | €600k |
| Theolytics | UK | 1 | €0 |
| Series C |
| €79M |
| 2018-10 |
| IOmx Therapeutics | Series B | €65M | 2021-10 |
| NRG Therapeutics | Series B | €58M | 2025-09 |
| ReproNovo | Series A | €57M | 2025-05 |
| Storm Therapeutics | Series C | €48M | 2026-04 |
| Lightcast Discovery | Series B | €45M | 2023-08 |
| FoRx Therapeutics | Series A | €43M | 2025-12 |
